During the past decade, Flaum Eye Institute at the University of Rochester conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Flaum Eye Institute at the University of Rochester" #1 sponsor was "University of Rochester" with 9 trials, followed by "Quark Pharmaceuticals" with 2 trials sponsored, "Calm Water Therapeutics LLC" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "National Eye Institute (NEI)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Flaum Eye Institute at the University of Rochester" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Bausch & Lomb Incorporated" with 2 trials as a collaborator, "Boston Sight" with 1 trials as a collaborator, "Envision Solutions, LLC" with 1 trials as a collaborator and "Milton S. Hershey Medical Center" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Flaum Eye Institute at the University of Rochester" are "Dry Eye" (2 trials), "Healthy" (2 trials), "Hemianopia" (2 trials), "Quadrantanopia" (2 trials) and "Sjogren's Disease" (2 trials). Many other conditions were trialed in "Flaum Eye Institute at the University of Rochester" in a lesser frequency.

Most popular intervention types in "Flaum Eye Institute at the University of Rochester" are "Drug" (10 trials), "Device" (3 trials), "Other" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetazolamide" (1 trials), "Administration of Lotemax" (1 trials), "Aflibercept" (1 trials), "Aflibercept Injection" (1 trials) and "B & L Soothe Lubricant Eye Drops" (1 trials). Other intervention names were less common.

The vast majority of trials in "Flaum Eye Institute at the University of Rochester" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Flaum Eye Institute at the University of Rochester". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Flaum Eye Institute at the University of Rochester, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Flaum Eye Institute at the University of Rochester, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".